BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27717368)

  • 1. Overview of harm reduction in prisons in seven European countries.
    Sander G; Scandurra A; Kamenska A; MacNamara C; Kalpaki C; Bessa CF; Laso GN; Parisi G; Varley L; Wolny M; Moudatsou M; Pontes NH; Mannix-McNamara P; Libianchi S; Antypas T
    Harm Reduct J; 2016 Oct; 13(1):28. PubMed ID: 27717368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV, Hepatitis C, TB, Harm Reduction, and Persons Deprived of Liberty: What Standards Does International Human Rights Law Establish?
    Sander G; Lines R
    Health Hum Rights; 2016 Dec; 18(2):171-182. PubMed ID: 28559684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global State of Harm Reduction in Prisons.
    Sander G; Shirley-Beavan S; Stone K
    J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
    Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
    Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The furthest left behind: the urgent need to scale up harm reduction in prisons.
    Sander G; Murphy F
    Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases.
    Stöver H; Tarján A; Horváth G; Montanari L
    Harm Reduct J; 2021 Jun; 18(1):67. PubMed ID: 34187471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.
    Stöver H; Meroueh F; Marco A; Keppler K; Saiz de la Hoya P; Littlewood R; Wright N; Nava F; Alam F; Walcher S; Somaini L
    BMC Public Health; 2019 Jan; 19(1):30. PubMed ID: 30621658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to reduce HIV transmission related to injecting drug use in prison.
    Jürgens R; Ball A; Verster A
    Lancet Infect Dis; 2009 Jan; 9(1):57-66. PubMed ID: 19095196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prisoners who inject drugs: public health and human rights imperatives.
    Jürgens R; Betteridge G
    Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harm reduction and women in the Canadian national prison system: policy or practice?
    Rehman L; Gahagan J; DiCenso AM; Dias G
    Women Health; 2004; 40(4):57-73. PubMed ID: 15911510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV, prisoners, and human rights.
    Rubenstein LS; Amon JJ; McLemore M; Eba P; Dolan K; Lines R; Beyrer C
    Lancet; 2016 Sep; 388(10050):1202-14. PubMed ID: 27427457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary women prisoners health experiences, unique prison health care needs and health care outcomes in sub Saharan Africa: a scoping review of extant literature.
    Van Hout MC; Mhlanga-Gunda R
    BMC Int Health Hum Rights; 2018 Aug; 18(1):31. PubMed ID: 30081894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The politics of harm reduction in federal prisons.
    Watson TM
    Int J Drug Policy; 2014 Sep; 25(5):916-23. PubMed ID: 25018152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indonesian prisons and HIV: part of the problem, part of the solution?
    Nelwan EJ; Diana A; van Crevel R; Alam NN; Alisjahbana B; Pohan HT; van der Ven A; Djaya I
    Acta Med Indones; 2009 Jul; 41 Suppl 1():52-6. PubMed ID: 19920299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
    Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):391-400. PubMed ID: 33857445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opening the Door to Zero New HIV Infections in Closed Settings.
    Torriente A; Tadion A; Hsu LN
    Health Hum Rights; 2016 Jun; 18(1):157-168. PubMed ID: 27781007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring harm reduction in European prisons via the Dublin Declaration.
    Lines R; Stöver H; Donochoe MC; Lazarus JV
    Int J Prison Health; 2009; 5(4):251-5. PubMed ID: 25757526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.